Antiviral Agents* / pharmacokinetics

Oral COVID-19 Treatment VV116 Shows Promise with Minimal Impact from Liver Impairment A new oral antiviral, VV116 (too known as mindeudesivir), is demonstrating encouraging results in clinical trials for the …

Remdesivir for COVID-19: A Comprehensive Update Remdesivir, developed by Gilead Sciences, holds a significant place in the history of COVID-19 treatment. As the first drug to receive U.S. Food and …

Stability-Indicating HPLC Method for Remdesivir analysis in Pharmaceutical Formulations and Bioavailability Studies Table of Contents Stability-Indicating HPLC Method for Remdesivir analysis in Pharmaceutical Formulations and Bioavailability Studies Background on Remdesivir …